259 related articles for article (PubMed ID: 21936567)
1. Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of EEF1D as a substrate for CK2.
Gyenis L; Duncan JS; Turowec JP; Bretner M; Litchfield DW
J Proteome Res; 2011 Nov; 10(11):4887-901. PubMed ID: 21936567
[TBL] [Abstract][Full Text] [Related]
2. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
Gyenis L; Turowec JP; Bretner M; Litchfield DW
Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
[TBL] [Abstract][Full Text] [Related]
3. An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets.
Duncan JS; Gyenis L; Lenehan J; Bretner M; Graves LM; Haystead TA; Litchfield DW
Mol Cell Proteomics; 2008 Jun; 7(6):1077-88. PubMed ID: 18258654
[TBL] [Abstract][Full Text] [Related]
4. Functional proteomics strategy for validation of protein kinase inhibitors reveals new targets for a TBB-derived inhibitor of protein kinase CK2.
Gyenis L; Kuś A; Bretner M; Litchfield DW
J Proteomics; 2013 Apr; 81():70-9. PubMed ID: 23017496
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase CK2 is a constitutively active enzyme that promotes cell survival: strategies to identify CK2 substrates and manipulate its activity in mammalian cells.
Turowec JP; Duncan JS; French AC; Gyenis L; St Denis NA; Vilk G; Litchfield DW
Methods Enzymol; 2010; 484():471-93. PubMed ID: 21036246
[TBL] [Abstract][Full Text] [Related]
6. Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach.
Borgo C; Cesaro L; Hirota T; Kuwata K; D'Amore C; Ruppert T; Blatnik R; Salvi M; Pinna LA
Eur J Med Chem; 2021 Mar; 214():113217. PubMed ID: 33548633
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells.
Franchin C; Cesaro L; Salvi M; Millioni R; Iori E; Cifani P; James P; Arrigoni G; Pinna L
Biochim Biophys Acta; 2015 Jun; 1854(6):609-23. PubMed ID: 25278378
[TBL] [Abstract][Full Text] [Related]
8. Detection of phospho-sites generated by protein kinase CK2 in CFTR: mechanistic aspects of Thr1471 phosphorylation.
Venerando A; Franchin C; Cant N; Cozza G; Pagano MA; Tosoni K; Al-Zahrani A; Arrigoni G; Ford RC; Mehta A; Pinna LA
PLoS One; 2013; 8(9):e74232. PubMed ID: 24058532
[TBL] [Abstract][Full Text] [Related]
9. Chimeric peptides as modulators of CK2-dependent signaling: Mechanism of action and off-target effects.
Zanin S; Sandre M; Cozza G; Ottaviani D; Marin O; Pinna LA; Ruzzene M
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1694-707. PubMed ID: 25936516
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase CK2 phosphorylation of SAPS3 subunit increases PP6 phosphatase activity with Aurora A kinase.
Heo J; Larner JM; Brautigan DL
Biochem J; 2020 Jan; 477(2):431-444. PubMed ID: 31904830
[TBL] [Abstract][Full Text] [Related]
11. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.
Leung KK; Shilton BH
Biochemistry; 2015 Jan; 54(1):47-59. PubMed ID: 25379648
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.
Laudet B; Barette C; Dulery V; Renaudet O; Dumy P; Metz A; Prudent R; Deshiere A; Dideberg O; Filhol O; Cochet C
Biochem J; 2007 Dec; 408(3):363-73. PubMed ID: 17714077
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.
Franck N; Le Seyec J; Guguen-Guillouzo C; Erdtmann L
J Virol; 2005 Mar; 79(5):2700-8. PubMed ID: 15708989
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle regulatory protein p27KIP1 is a substrate and interacts with the protein kinase CK2.
Tapia JC; Bolanos-Garcia VM; Sayed M; Allende CC; Allende JE
J Cell Biochem; 2004 Apr; 91(5):865-79. PubMed ID: 15034923
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of inhibitor-responsive kinase substrates using a new paradigm to measure kinase-specific protein phosphorylation index.
Li X; Rao V; Jin J; Guan B; Anderes KL; Bieberich CJ
J Proteome Res; 2012 Jul; 11(7):3637-49. PubMed ID: 22663298
[TBL] [Abstract][Full Text] [Related]
16. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA
J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294
[TBL] [Abstract][Full Text] [Related]
17. Casein kinase 2 binds and phosphorylates the nucleosome assembly protein-1 (NAP1) in Drosophila melanogaster.
Li M; Strand D; Krehan A; Pyerin W; Heid H; Neumann B; Mechler BM
J Mol Biol; 1999 Nov; 293(5):1067-84. PubMed ID: 10547286
[TBL] [Abstract][Full Text] [Related]
18. Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis.
Salvi M; Sarno S; Cesaro L; Nakamura H; Pinna LA
Biochim Biophys Acta; 2009 May; 1793(5):847-59. PubMed ID: 19339213
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase CK2 phosphorylates and upregulates Akt/PKB.
Di Maira G; Salvi M; Arrigoni G; Marin O; Sarno S; Brustolon F; Pinna LA; Ruzzene M
Cell Death Differ; 2005 Jun; 12(6):668-77. PubMed ID: 15818404
[TBL] [Abstract][Full Text] [Related]
20. Identification of Endogenous Kinase Substrates by Proximity Labeling Combined with Kinase Perturbation and Phosphorylation Motifs.
Niinae T; Imami K; Sugiyama N; Ishihama Y
Mol Cell Proteomics; 2021; 20():100119. PubMed ID: 34186244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
